Skip to Main Content
Beta test
our new site.
(
NLM Technical Bulletin
)
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Cannabis and Schizophrenia: Self-Medication and Agonist Treatment
This study has been completed.
Study NCT00946348 Information provided by Dartmouth-Hitchcock Medical Center
First Received on July 24, 2009. Last Updated on April 25, 2013
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Schizophrenia
Dual Diagnosis
Schizoaffective Disorder
Psychotic Disorder
Cannabis Use Disorder
Additional conditions recognized in this trial
Mental Disorders
Psychotic Disorders
More general conditions related to this trial
Schizophrenia and Disorders with Psychotic Features
Interventions listed in this trial
Dronabinol
Cannabis
Additional drug interventions recognized in this trial
Tetrahydrocannabinol
More general drug interventions related to this trial
Analgesics
Analgesics, Non-Narcotic
Central Nervous System Agents
Hallucinogens
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Psychotropic Drugs
Sensory System Agents
Therapeutic Uses
Sponsors listed in this trial
Dartmouth-Hitchcock Medical Center
National Institute on Drug Abuse (NIDA)
Indiana University
Columbia University
University of Vermont
University of Massachusetts, Worcester
Back to top of Main Content
